Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 3 [51-123]
Ligand
BDBM50092310
Substrate
n/a
Meas. Tech.
Biolayer Interferometry (BLI) Binding Assay
pH
7.4000±n/a
Kd
18±2.50 nM
Comments
extracted
Citation
 Wang, S; Ran, X; Zhao, Y; Yang, C; Liu, L; Bai, L; McEachern, D; Stuckey, J; Meagher, JL; Sun, D; Li, X; Zhou, B; Karatas, H; Luo, R; Chinnaiyan, A; Asangani, IA BET bromodomain inhibitors and therapeutic methods using the same US Patent  US9675697 Publication Date 6/13/2017 
Target
Name:
Bromodomain-containing protein 3 [51-123]
Synonyms:
Bromodomain-containing protein 3 Bromo 1 domain(BRD3 BD1) | Bromodomain-containing protein 3 (BRD3)(BD1) | BRD3_HUMAN | BRD3 | KIAA0043 | RING3L
Type:
n/a
Mol. Mass.:
8887.10
Organism:
Human
Description:
BD1 (51-123 aa) of Q15059
Residue:
73
Sequence:
WKHQFAWPFYQPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTDDIV
  
Inhibitor
Name:
BDBM50092310
Synonyms:
US9675697, Cpd. No. 23 | CHEMBL3581661
Type:
Small organic molecule
Emp. Form.:
TBD
Mol. Mass.:
TBD
SMILES:
TBD
Structure:
Search PDB for entries with ligand similarity: